Publication Name	World Journal of Orthopedics
Manuscript ID	26842
Country	India

Received	2016-04-28 10:31
Peer-Review Started	2016-04-28 21:52
To Make the First Decision	2016-06-12 09:26
Return for Revision	2016-06-16 11:54
Revised	2016-06-21 01:43
Second Decision	2016-06-27 16:52
Accepted by Journal Editor-in-Chief	2016-06-29 19:02
Accepted by Company Editor-in-Chief	2016-07-13 13:45
Articles in Press	2016-07-13 13:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-09-02 19:33
Publish the Manuscript Online	2016-09-12 08:40

ISSN	2218-5836 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Management of Ewing sarcoma family of tumors: Current scenario and unmet need
Manuscript Source	Invited Manuscript
All Author List	Bivas Biswas and Sameer Bakhshi
Funding Agency and Grant Number	Funding Agency Grant Number
Corresponding Author	Dr. Bivas Biswas, Assistant Professor, Department of Medical Oncology, Dr.B.R.A.I.R.C.H, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. bivasbiswas@gmail.com
Key Words	Outcome; Review; Chemotherapy; Ewing sarcoma; Targeted therapy; Radiotherapy; Prognostic factors
Core Tip	Ewing sarcoma family tumors are a heter-ogeneous and aggressive group of disease of bone and soft tissue in childhood. The outcome has improved with introduction of chemotherapy and multimoda-lity management. But, the prognosis of patients with metastatic disease is dismal. Novel targeted therapies are investigational and may offer some hope in future, especially in metastatic setting. In this review we have discussed current treatment modality, prognostic factors, ongoing trials and novel investigational therapies.
Publish Date	2016-09-12 08:40
Citation	Biswas B, Bakhshi S. Management of Ewing sarcoma family of tumors: Current scenario and unmet need. World J Orthop 2016; 7(9): 527-538
URL	http://www.wjgnet.com/2218-5836/full/v7/i9/527.htm
DOI	http://dx.doi.org/10.5312/wjo.v7.i9.527

Full Article (PDF)	WJO-7-527.pdf
Full Article (Word)	WJO-7-527.doc
Manuscript File	26842-Review.docx
Answering Reviewers	26842-Answering reviewers.pdf
Audio Core Tip	26842-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	26842-Conflict-of-interest statement.pdf
Copyright License Agreement	26842-Copyright assignment.pdf
Peer-review Report	26842-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	26842-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	26842-Scientific misconduct check.pdf
Scientific Editor Work List	26842-Scientific editor work list.pdf